Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kotak Mahindra Capital is an Indian full-service investment bank and a subsidiary of Kotak Mahindra Bank. The firm provides equity capital markets execution, mergers and acquisitions advisory, private equity advisory, and related capital-markets and corporate-finance services to Indian companies, multinational corporations, and financial sponsors. It operates under the Kotak Investment Banking brand and has sector coverage that includes healthcare and pharmaceuticals among many other industries, but it is not itself a life sciences or healthcare operating company. For biotech analysts, the company is best understood as a financial intermediary and advisor rather than a drug developer, healthcare provider, or medical technology company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kotak Mahindra Capital.